← Leaderboards
Martin Benej
Ohio State University
$524,296
Attributed
$524,296
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $262.1K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$524,296 · 2
By mechanism
K22$366,796 · 1
R03$157,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Ohio State University
Same institution · by research overlap
- Nicholas C Denko$10,501,039
- Zihai Li$25,199,729
- Selvendiran Karuppaiyah$1,616,031
- Michael R Grever$17,739,693
- Tsonwin Hai$4,164,066
Others in their field
Other Rising Stars on “Luciferases”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Reeder McNeil Robinson · Leukogene Therapeutics, Inc.$2,940,211
- Robert Marsden Cox · Emory University$2,817,180
- Maria Mavrikaki · Beth Israel Deaconess Medical Center$2,525,941
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- Ashish Kapoor · University Of Texas Hlth Sci Ctr Houston$2,119,646
Research focus
LuciferasesIn VivoImmune TargetingImmune ResistanceInhibitorIn VitroHypoxiaGenesImmune Cell InfiltrateImmune Checkpoint BlockadeImpairmentInfiltrationCessation Of LifeInnovationFoundationsDisorder ControlClinical ManagementClinical TranslationCancer PatientImmuneCancer TherapyImmune CheckpointImmunotherapyMalignant Neoplasm Of Lung
Grant awards (4)
Targeting mitochondrial oxygen demand to overcome hypoxic immune privilege of NSCLC tumors$183,398
K22 · FY2025 · CA · contact PI
Targeting mitochondrial oxygen demand to overcome hypoxic immune privilege of NSCLC tumors$183,398
K22 · FY2024 · CA · contact PI
Validation of OXPHOS gene amplification as a driver of hypoxia and treatment resistance in NSCLC$78,750
R03 · FY2024 · CA · contact PI
Validation of OXPHOS gene amplification as a driver of hypoxia and treatment resistance in NSCLC$78,750
R03 · FY2023 · CA · contact PI